Agenda | |
|---|---|
6:00 – 6:30 am | Registration and Breakfast |
6:30 – 6:35 am | Opening Remarks |
6:35 – 6:50 am | Overview of Insulin Therapy in T2DM |
6:50 – 7:05 am | Basal Insulin: A Deeper Dive |
7:05 – 7:25 am | Role of CGM in Insulin Therapy & Minimizing Hypoglycemia with Insulins |
7:25 – 7:55 am | Bringing it All Together: Patient Cases & Expert Discussion |
7:55 – 8:00 am | Closing Remarks and Q&A |
Join us for breakfast
Join the experts in this symposium as they cover a variety of topics surrounding the role of insulin therapy in type 2 diabetes (T2D) management, including practical pearls for initiation and maintenance of insulin therapy, how insulin therapy fits in with other T2D treatment options, and emerging insulin options.
Faculty
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Henry Ford Health System
Division of Endocrinology, Diabetes, Bone and Mineral Disease
Detroit, MI
Jay H. Shubrook, DO
Professor, and Interim Chair
Department of Clinical Sciences and Community Health
Diabetologist
Touro University California College of Osteopathic Medicine
Vallejo, CA
Reserve Your Seat
Pre-Register below to be added to our VIP attendance list and be given priority to join this event. Registration to this event is complimentary, however you must be a registered attendee of the 2023 AAFP FMX.
CME Information
This activity has been approved for AMA PRA Category 1 Credit(s)™. Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
This activity is jointly provided by Partners for Advancing Clinical Education and Cardiometabolic Health Congress. This satellite symposium is supported by an educational grant from Novo Nordisk. This event is not a part of the official AAFP FMX.
